Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0AL3O
|
||||
| Former ID |
DIB009483
|
||||
| Drug Name |
VX-366
|
||||
| Synonyms |
Isobutyramide; Isobutyramide, Vertex
|
||||
| Indication | Hematopoietic [ICD10:D50-D89] | Discontinued in Phase 2 | [546039] | ||
| Company |
Vertex Pharmaceuticals Inc
|
||||
| Canonical SMILES |
C(=O)(N)C(C)C
|
||||
| CAS Number |
CAS 563-83-7
|
||||
| Target and Pathway | |||||
| Target(s) | Hemoglobin | Target Info | Inhibitor | [525637] | |
| KEGG Pathway | African trypanosomiasis | ||||
| Malaria | |||||
| WikiPathways | Binding and Uptake of Ligands by Scavenger Receptors | ||||
| Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | |||||
| Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes | |||||
| Factors involved in megakaryocyte development and platelet production | |||||
| Folate Metabolism | |||||
| Vitamin B12 Metabolism | |||||
| Selenium Micronutrient Network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.